Sulfatide increases adiponectin and decreases TNF-α, IL-6, and IL-8 in human adipose tissue in vitro

Molecular and Cellular Endocrinology

Volumn 263, Issue 1-2, 2007, Pages 142-148

  Bruun, Jens M ^a   Roeske Nielsen, Allan ^b   Richelsen, Bjørn ^a   Fredman, Pam ^c   Buschard, Karsten ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adipokines; Adiponectin; Adipose tissue (human); IL 6; IL 8; Inflammation; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ADIPONECTIN; CARBON; GLIBENCLAMIDE; INTERLEUKIN 6; INTERLEUKIN 8; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SATURATED FATTY ACID; SULFATIDE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SWINE; TISSUE CULTURE; UPREGULATION;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ADULT; ANIMALS; CELLS, CULTURED; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; OBESITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFOGLYCOSPHINGOLIPIDS; SWINE; TUMOR NECROSIS FACTOR-ALPHA; WOMEN;

EID: 34248376872     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.09.008     Document Type: Article

References (35)

1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
2. Bastard J.P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., and Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85 (2000) 3338-3342
3. Blomqvist M., Osterbye T., Mansson J.E., Horn T., Buschard K., and Fredman P. Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type 2 diabetic animal models. APMIS 111 (2003) 867-877
4. Bovin L.F., Fredman P., Mansson J.E., Buschard K., and Bendtzen K. In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide. FEBS Lett. 455 (1999) 339-343
5. Bruun J.M., Lihn A.S., Pedersen S.B., and Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT). Implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 90 (2005) 2282-2289
6. Bruun J.M., Lihn A.S., Verdich C., Pedersen S.B., Toubro S., Astrup A., and Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E527-E533
7. Bruun J.M., Pedersen S.B., and Richelsen B. Interleukin-8 production in human adipose tissue. Inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanide metformin. Horm. Metab. Res. 32 (2000) 537-541
8. Bruun J.M., Pedersen S.B., and Richelsen B. Regulation of interleukin-8 production and gene expression in human adipose tissue in vitro. J. Clin. Endocrinol. Metab. 86 (2001) 1267-1273
9. Buschard K., Diamant M., Bovin L.E., Mansson J.E., Fredman P., and Bendtzen K. Sulphatide and its precursor galactosylceramide influence the production of cytokines in human mononuclear cells. APMIS 104 (1996) 938-944
10. Buschard K., Fredman P., Bøg-Hansen E., Blomqvist M., Hedner J., Råstam L., and Lindblad U. Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with type 2 diabetes. The Skaraborg project. Diabetic Med. 22 (2005) 1190-1198
11. Buschard K., Hoy M., Bokvist K., Olsen H.L., Madsbad S., Fredman P., and Gromada J. Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells. Diabetes 51 (2002) 2514-2521
12. Coppack S.W., Lant A.F., McIntosh C.S., and Rodgers A.V. Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus. Br. J. Clin. Pharmacol. 29 (1990) 673-684
13. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25 (2004) 4-7
14. Delaigle A.M., Jonas J.C., Bauche I.B., Cornu O., and Brichard S.M. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 145 (2004) 5589-5597
15. Desfaits A.C., Serri O., and Renier G. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care 21 (1998) 487-493
16. Despres J.P., Lemieux I., and Prud'homme D. Treatment of obesity: need to focus on high-risk abdominally obese patients. BMJ 322 (2001) 716-720
17. Fain J.N., Cheema P.S., Bahouth S.W., and Lloyd H.M. Resistin release by human adipose tissue explants in primary culture. Biochem. Biophys. Res. Commun. 300 (2003) 674-678
18. Fredman P., Mansson J.E., Rynmark B.M., Josefsen K., Ekblond A., Halldner L., Osterbye T., Horn T., and Buschard K. The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking. Glycobiology 10 (2000) 39-50
19. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 (1998) 847-850
20. Fukuzawa M., Satoh J., Qiang X., Miyaguchi S., Sakata Y., Nakazawa T., Ikehata F., Ohta S., and Toyota T. Inhibition of tumor necrosis factor-alpha with anti-diabetic agents. Diabetes Res. Clin. Pract. 43 (1999) 147-154
21. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
22. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., and Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1595-1599
23. Kobashi C., Urakaze M., Kishida M., Kibayashi E., Kobayashi H., Kihara S., Funahashi T., Takata M., Temaru R., Sato A., Yamazaki K., Nakamura N., and Kobayashi M. Adiponectin inhibits endothelial synthesis of interleukin-8. Circ. Res. 97 (2005) 1245-1252
24. Mansson J.E., Mo H.Q., Egge H., and Svennerholm L. Trisialosyllactosylceramide (GT3) is a ganglioside of human lung. FEBS Lett. 196 (1986) 259-262
25. Osterbye T., Jorgensen K.H., Fredman P., Tranum-Jensen J., Kaas A., Brange J., Whittingham J.L., and Buschard K. Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization. Glycobiology 11 (2001) 473-479
26. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004) 813-823
27. Roeske-Nielsen A., Fredman P., Mansson J.E., Bendtzen K., and Buschard K. Beta-galactosylceramide increases and sulfatide decreases cytokine and chemokine production in whole blood cells. Immunol. Lett. 91 (2004) 205-211
28. Shi H., Moustaid-Moussa N., Wilkison W.O., and Zemel M.B. Role of the sulfonylurea receptor in regulating human adipocyte metabolism. FASEB J. 13 (1999) 1833-1838
29. Silva-Santos J.E., Santos-Silva M.C., Cunha F.Q., and Assreuy J. The role of ATP-sensitive potassium channels in neutrophil migration and plasma exudation. J. Pharmacol. Exp. Ther. 300 (2002) 946-951
30. Straczkowski M., Dzienis-Straczkowska S., Stepien A., Kowalska I., Szelachowska M., and Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J. Clin. Endocrinol. Metab. 87 (2002) 4602-4606
31. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
32. Wolf A.M., Wolf D., Rumpold H., Enrich B., and Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun. 323 (2004) 630-635
33. Wulster-Radcliffe M.C., Ajuwon K.M., Wang J., Christian J.A., and Spurlock M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun. 316 (2004) 924-929
34. Yudkin J.S., Panahloo A., Stehouwer C., Emeis J.J., Bulmer K., Mohamed-Ali V., and Denver A.E. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in type II diabetic subjects. Diabetologia 43 (2000) 1099-1106
35. Zozulinska D., Majchrzak A., Sobieska M., Wiktorowicz K., and Wierusz-Wysocka B. Serum interleukin-8 level is increased in diabetic patients (letter). Diabetologia 42 (1999) 117-118